GSK Cervarix Setback: FDA Questions On HPV Vaccine Bode Well For Merck

The launch of GlaxoSmithKline human papilloma virus vaccine Cervarix will be further delayed behind Merck's competing Gardasil vaccine after FDA issued a "complete response" letter related to the BLA Dec. 17